Neisseria Meningitidis Completed Phase 3 Trials for Streptococcus pneumoniae type 23f capsular polysaccharide diphtheria crm197 protein conjugate antigen (DB10292)

DBCOND0030896 (Neisseria Meningitidis)Completed3 IdentifierTitlePurposeDrugs
NCT00289783Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate VaccinePrevention
NCT00345683Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 12 to 15 Months of Age.Prevention